Detalles de la búsqueda
1.
Role of Iodine-Assisted Aerosol Particle Formation in Antarctica.
Environ Sci Technol
; 58(17): 7314-7324, 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38626432
2.
Improved patient- and caregiver-reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitis.
J Eur Acad Dermatol Venereol
; 2024 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357778
3.
Direct field evidence of autocatalytic iodine release from atmospheric aerosol.
Proc Natl Acad Sci U S A
; 118(4)2021 01 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33479177
4.
The IL-4Rα Q576R polymorphism is associated with increased severity of atopic dermatitis and exaggerates allergic skin inflammation in mice.
J Allergy Clin Immunol
; 151(5): 1296-1306.e7, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36690254
5.
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment.
J Allergy Clin Immunol
; 152(5): 1179-1195, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315812
6.
Tralokinumab treatment improves the skin microbiota by increasing the microbial diversity in adults with moderate-to-severe atopic dermatitis: Analysis of microbial diversity in ECZTRA 1, a randomized controlled trial.
J Am Acad Dermatol
; 88(4): 816-823, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36473633
7.
Abrocitinib efficacy and safety in patients with moderate-to-severe atopic dermatitis: Results from phase 3 studies, including the long-term extension JADE EXTEND study.
J Eur Acad Dermatol Venereol
; 37(10): 2056-2066, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335885
8.
Upadacitinib treatment withdrawal and retreatment in patients with moderate-to-severe atopic dermatitis: Results from a phase 2b, randomized, controlled trial.
J Eur Acad Dermatol Venereol
; 37(12): 2558-2568, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37528500
9.
Signaling sphingolipids are biomarkers for atopic dermatitis prone to disseminated viral infections.
J Allergy Clin Immunol
; 150(3): 640-648, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35304160
10.
Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors.
J Allergy Clin Immunol
; 149(1): 145-155, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34111454
11.
JAK Signaling Is Critically Important in Cytokine-Induced Viral Susceptibility of Keratinocytes.
Int J Mol Sci
; 24(11)2023 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37298195
12.
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper.
Allergy
; 77(6): 1736-1750, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741557
13.
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
Pediatr Dermatol
; 39(2): 187-196, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083774
14.
Multiethnic genome-wide and HLA association study of total serum IgE level.
J Allergy Clin Immunol
; 148(6): 1589-1595, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34536413
15.
Skin barrier defects in atopic dermatitis: From old idea to new opportunity.
Allergol Int
; 71(1): 3-13, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34916117
16.
Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticum.
Allergy
; 76(8): 2510-2523, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33548076
17.
On the cause and consequences of IgE to galactose-α-1,3-galactose: A report from the National Institute of Allergy and Infectious Diseases Workshop on Understanding IgE-Mediated Mammalian Meat Allergy.
J Allergy Clin Immunol
; 145(4): 1061-1071, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32057766
18.
Upadacitinib in adults with moderate to severe atopic dermatitis: 16-week results from a randomized, placebo-controlled trial.
J Allergy Clin Immunol
; 145(3): 877-884, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31786154
19.
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.
J Am Acad Dermatol
; 83(5): 1282-1293, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32574587
20.
Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study.
J Am Acad Dermatol
; 82(2): 377-388, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31374300